0000766704false2023Q2December 31P1Yhttp://www.welltower.com/20230630#LeaseRightOfUseAssethttp://www.welltower.com/20230630#LeaseRightOfUseAssethttp://www.welltower.com/20230630#LeaseRightOfUseAssethttp://www.welltower.com/20230630#LeaseRightOfUseAssethttp://www.welltower.com/20230630#ReceivablesAndOtherAssetshttp://www.welltower.com/20230630#ReceivablesAndOtherAssetshttp://fasb.org/us-gaap/2023#RealEstateHeldforsalehttp://fasb.org/us-gaap/2023#RealEstateHeldforsalehttp://www.welltower.com/20230630#LeaseLiabilityhttp://www.welltower.com/20230630#LeaseLiabilityhttp://www.welltower.com/20230630#LeaseLiabilityhttp://www.welltower.com/20230630#LeaseLiability0.0104808P3Y00007667042023-01-012023-06-300000766704us-gaap:CommonStockMember2023-01-012023-06-300000766704well:GuaranteeNotesDue20284800Member2023-01-012023-06-300000766704well:GuaranteeNotesDue20344500Member2023-01-012023-06-3000007667042023-07-28xbrli:shares00007667042023-06-30iso4217:USD00007667042022-12-310000766704us-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:ManagementServiceMember2022-04-012022-06-300000766704us-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:ManagementServiceMember2022-01-012022-06-3000007667042023-04-012023-06-3000007667042022-04-012022-06-3000007667042022-01-012022-06-300000766704well:InterestRevenueMember2023-04-012023-06-300000766704well:InterestRevenueMember2022-04-012022-06-300000766704well:InterestRevenueMember2023-01-012023-06-300000766704well:InterestRevenueMember2022-01-012022-06-300000766704us-gaap:ProductAndServiceOtherMember2023-04-012023-06-300000766704us-gaap:ProductAndServiceOtherMember2022-04-012022-06-300000766704us-gaap:ProductAndServiceOtherMember2023-01-012023-06-300000766704us-gaap:ProductAndServiceOtherMember2022-01-012022-06-30iso4217:USDxbrli:shares0000766704us-gaap:CommonStockMember2022-12-310000766704us-gaap:AdditionalPaidInCapitalMember2022-12-310000766704us-gaap:TreasuryStockCommonMember2022-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2022-12-310000766704well:AccumulatedDistributionsMember2022-12-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000766704us-gaap:NoncontrollingInterestMember2022-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-01-012023-03-310000766704us-gaap:NoncontrollingInterestMember2023-01-012023-03-3100007667042023-01-012023-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000766704us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000766704us-gaap:CommonStockMember2023-01-012023-03-310000766704us-gaap:TreasuryStockCommonMember2023-01-012023-03-310000766704well:AccumulatedDistributionsMember2023-01-012023-03-310000766704us-gaap:CommonStockMember2023-03-310000766704us-gaap:AdditionalPaidInCapitalMember2023-03-310000766704us-gaap:TreasuryStockCommonMember2023-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-03-310000766704well:AccumulatedDistributionsMember2023-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000766704us-gaap:NoncontrollingInterestMember2023-03-3100007667042023-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-04-012023-06-300000766704us-gaap:NoncontrollingInterestMember2023-04-012023-06-300000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300000766704us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300000766704us-gaap:CommonStockMember2023-04-012023-06-300000766704us-gaap:TreasuryStockCommonMember2023-04-012023-06-300000766704well:AccumulatedDistributionsMember2023-04-012023-06-300000766704us-gaap:CommonStockMember2023-06-300000766704us-gaap:AdditionalPaidInCapitalMember2023-06-300000766704us-gaap:TreasuryStockCommonMember2023-06-300000766704us-gaap:RetainedEarningsUnappropriatedMember2023-06-300000766704well:AccumulatedDistributionsMember2023-06-300000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300000766704us-gaap:NoncontrollingInterestMember2023-06-300000766704us-gaap:CommonStockMember2021-12-310000766704us-gaap:AdditionalPaidInCapitalMember2021-12-310000766704us-gaap:TreasuryStockCommonMember2021-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2021-12-310000766704well:AccumulatedDistributionsMember2021-12-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000766704us-gaap:NoncontrollingInterestMember2021-12-3100007667042021-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2022-01-012022-03-310000766704us-gaap:NoncontrollingInterestMember2022-01-012022-03-3100007667042022-01-012022-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000766704us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310000766704us-gaap:CommonStockMember2022-01-012022-03-310000766704us-gaap:TreasuryStockCommonMember2022-01-012022-03-310000766704well:AccumulatedDistributionsMember2022-01-012022-03-310000766704us-gaap:CommonStockMember2022-03-310000766704us-gaap:AdditionalPaidInCapitalMember2022-03-310000766704us-gaap:TreasuryStockCommonMember2022-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2022-03-310000766704well:AccumulatedDistributionsMember2022-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000766704us-gaap:NoncontrollingInterestMember2022-03-3100007667042022-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2022-04-012022-06-300000766704us-gaap:NoncontrollingInterestMember2022-04-012022-06-300000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300000766704us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300000766704us-gaap:CommonStockMember2022-04-012022-06-300000766704us-gaap:TreasuryStockCommonMember2022-04-012022-06-300000766704well:AccumulatedDistributionsMember2022-04-012022-06-300000766704us-gaap:CommonStockMember2022-06-300000766704us-gaap:AdditionalPaidInCapitalMember2022-06-300000766704us-gaap:TreasuryStockCommonMember2022-06-300000766704us-gaap:RetainedEarningsUnappropriatedMember2022-06-300000766704well:AccumulatedDistributionsMember2022-06-300000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300000766704us-gaap:NoncontrollingInterestMember2022-06-3000007667042022-06-300000766704well:WelltowerOPIncMember2023-01-012023-06-30xbrli:pure0000766704well:WelltowerOPIncMember2023-06-300000766704well:WelltowerOPIncMemberwell:OtherInvestorsMember2023-06-300000766704well:COVID19Memberwell:SeniorHousingOperatingMember2023-04-012023-06-300000766704well:COVID19Memberwell:SeniorHousingOperatingMember2023-01-012023-06-300000766704well:COVID19Memberwell:SeniorHousingOperatingMember2022-04-012022-06-300000766704well:COVID19Memberwell:SeniorHousingOperatingMember2022-01-012022-06-300000766704well:SeniorHousingOperatingMember2023-06-300000766704well:TripleNetMember2023-06-300000766704well:OutpatientMedicalMember2023-06-300000766704well:SeniorHousingOperatingMember2022-06-300000766704well:TripleNetMember2022-06-300000766704well:OutpatientMedicalMember2022-06-300000766704well:SeniorHousingOperatingMember2023-01-012023-06-300000766704well:TripleNetMember2023-01-012023-06-300000766704well:OutpatientMedicalMember2023-01-012023-06-300000766704well:SeniorHousingOperatingMember2022-01-012022-06-300000766704well:TripleNetMember2022-01-012022-06-300000766704well:OutpatientMedicalMember2022-01-012022-06-300000766704well:HolidayRetirementMember2022-04-01well:property00007667042022-04-012022-04-010000766704us-gaap:OtherIncomeMember2022-04-012022-06-300000766704us-gaap:LeasesAcquiredInPlaceMember2023-06-300000766704us-gaap:LeasesAcquiredInPlaceMember2022-12-310000766704us-gaap:AboveMarketLeasesMember2023-06-300000766704us-gaap:AboveMarketLeasesMember2022-12-310000766704well:LeaseCommissionsMember2023-06-300000766704well:LeaseCommissionsMember2022-12-310000766704us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2023-06-300000766704us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2023-04-012023-06-300000766704us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2023-01-012023-06-300000766704us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2022-04-012022-06-300000766704us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2022-01-012022-06-300000766704well:PublicSectorPensionInvestmentBoardMember2023-04-012023-06-300000766704well:PublicSectorPensionInvestmentBoardMember2023-04-012023-06-300000766704well:PublicSectorPensionInvestmentBoardUKPortfolioMember2023-04-012023-06-300000766704well:UKPortfolioJointVenture1Member2023-06-300000766704well:UKPortfolioJointVenture2Member2023-06-300000766704well:PublicSectorPensionInvestmentBoardUKPortfolioMember2023-04-012023-06-300000766704well:UKPortfolioJointVenture1Member2023-04-012023-06-300000766704well:PublicSectorPensionInvestmentBoardUKPortfolioMember2023-06-300000766704us-gaap:SubsequentEventMemberwell:PublicSectorPensionInvestmentBoardUSPortfolioMember2023-07-012023-07-310000766704well:USPortfolioJointVentureMember2023-06-300000766704well:USPortfolioJointVentureMemberwell:ReveraMember2023-06-300000766704us-gaap:SubsequentEventMember2023-07-012023-07-310000766704us-gaap:SubsequentEventMemberwell:PublicSectorPensionInvestmentBoardUSPortfolioMember2023-07-012023-07-31well:project0000766704us-gaap:SubsequentEventMemberwell:PublicSectorPensionInvestmentBoardUSPortfolioMember2023-07-310000766704well:PublicSectorPensionInvestmentBoardUSPortfolioMember2023-04-012023-06-300000766704well:OakmontManagementGroupMember2023-06-300000766704well:CanadianPortfolioJointVentureMember2023-06-300000766704well:CanadianPortfolioJointVentureMemberwell:ReveraMember2023-06-300000766704srt:ScenarioForecastMemberwell:PublicSectorPensionInvestmentBoardCanadianPortfolioMember2023-01-012023-12-310000766704well:PublicSectorPensionInvestmentBoardCanadianPortfolioMembersrt:ScenarioForecastMember2023-01-012023-12-310000766704well:GenesisHealthCareOperatingRelationshipMember2021-03-012021-03-310000766704well:GenesisHealthCareOperatingRelationshipMember2021-03-310000766704well:GenesisHealthCareOperatingRelationshipMember2023-03-310000766704well:JointVentureWithAuroraHealthNetworkPeaceCapitalMember2023-05-012023-05-010000766704well:JointVentureWithAuroraHealthNetworkPeaceCapitalMember2023-05-0100007667042023-05-012023-05-010000766704srt:MinimumMember2023-01-012023-06-300000766704srt:MaximumMember2023-01-012023-06-300000766704us-gaap:CostOfSalesMember2023-01-012023-06-300000766704us-gaap:CostOfSalesMember2022-01-012022-06-300000766704us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-06-300000766704us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-06-300000766704us-gaap:OperatingSegmentsMember2023-06-300000766704us-gaap:OperatingSegmentsMember2022-12-310000766704us-gaap:CorporateNonSegmentMember2022-12-310000766704us-gaap:CorporateNonSegmentMember2023-06-300000766704well:OperatingSegmentsAndCorporateNonSegmentMember2023-06-300000766704well:OperatingSegmentsAndCorporateNonSegmentMember2022-12-310000766704us-gaap:MortgageReceivablesMember2023-06-300000766704us-gaap:MortgageReceivablesMember2022-12-310000766704well:OtherRealEstateLoansReceivablesMember2023-06-300000766704well:OtherRealEstateLoansReceivablesMember2022-12-310000766704us-gaap:RealEstateLoanMember2023-06-300000766704us-gaap:RealEstateLoanMember2022-12-310000766704well:DeterioratedLoansMember2023-06-30well:loan0000766704well:CollectiveLoanPool1Member2023-06-300000766704well:CollectiveLoanPool2Member2023-06-300000766704well:CollectiveLoanPool3Member2023-06-300000766704well:CollectiveLoanPool4Member2023-06-300000766704well:CollectiveLoanPool5Member2023-06-300000766704well:CollectiveLoanPool6Member2023-06-300000766704us-gaap:RealEstateLoanMember2023-06-300000766704well:SeniorsHousingOperatingMembersrt:MinimumMember2023-06-300000766704well:SeniorsHousingOperatingMembersrt:MaximumMember2023-06-300000766704well:SeniorsHousingOperatingMember2023-06-300000766704well:SeniorsHousingOperatingMember2022-12-310000766704well:TripleNetMembersrt:MinimumMember2023-06-300000766704srt:MaximumMemberwell:TripleNetMember2023-06-300000766704well:TripleNetMember2023-06-300000766704well:TripleNetMember2022-12-310000766704well:OutpatientMedicalMembersrt:MinimumMember2023-06-300000766704well:OutpatientMedicalMembersrt:MaximumMember2023-06-300000766704well:OutpatientMedicalMember2023-06-300000766704well:OutpatientMedicalMember2022-12-310000766704us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-06-30well:properties0000766704us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-01-012023-06-300000766704well:IntegraHealthcarePropertiesMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-06-300000766704well:IntegraHealthcarePropertiesMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-01-012023-06-300000766704well:SunriseSeniorLivingMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-06-300000766704well:SunriseSeniorLivingMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-01-012023-06-300000766704well:CogirManagementCorporationMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-06-300000766704well:CogirManagementCorporationMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-01-012023-06-300000766704well:StoryPointSeniorLivingMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-06-300000766704well:StoryPointSeniorLivingMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-01-012023-06-300000766704well:HCOneGroupMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-06-300000766704well:HCOneGroupMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-01-012023-06-300000766704well:RemainingPortfolioMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-06-300000766704well:RemainingPortfolioMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-01-012023-06-300000766704well:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-06-300000766704well:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-01-012023-06-300000766704well:HCOneGroupMember2023-06-30iso4217:GBPwell:bank0000766704us-gaap:RevolvingCreditFacilityMember2023-06-300000766704well:TermCreditFacilityMember2023-06-300000766704well:TermCreditFacilityCADDenominatedMember2023-06-30iso4217:CAD0000766704us-gaap:RevolvingCreditFacilityMemberwell:CreditFacilityTrancheDue2026Member2023-06-300000766704well:CreditFacilityTrancheDue2025Memberus-gaap:RevolvingCreditFacilityMember2023-06-30well:Term0000766704us-gaap:RevolvingCreditFacilityMember2023-01-012023-06-300000766704well:AccordionfeaturememberMemberus-gaap:RevolvingCreditFacilityMember2023-06-300000766704well:AccordionfeaturememberMemberwell:TermCreditFacilityCADDenominatedMember2023-06-300000766704us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-01-012023-06-300000766704srt:MaximumMemberus-gaap:CommercialPaperMember2023-01-012023-06-300000766704us-gaap:CommercialPaperMember2023-06-300000766704us-gaap:UnsecuredDebtMember2023-06-300000766704us-gaap:SecuredDebtMember2023-06-300000766704us-gaap:UnsecuredDebtMembersrt:MinimumMember2023-06-300000766704us-gaap:UnsecuredDebtMembersrt:MaximumMember2023-06-300000766704us-gaap:UnsecuredDebtMemberwell:A295SeniorUnsecuredNotesDue2023Member2023-06-300000766704us-gaap:SecuredDebtMembersrt:MinimumMember2023-06-300000766704us-gaap:SecuredDebtMembersrt:MaximumMember2023-06-300000766704us-gaap:UnsecuredDebtMemberwell:UnsecuredTermCreditFacilityMaturesJuly192023Member2023-06-300000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMember2023-06-30well:term0000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMember2023-01-012023-06-300000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-01-012023-06-300000766704us-gaap:UnsecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberwell:UnsecuredTermCreditFacilityMaturesJuly192023Member2023-06-300000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMemberwell:CanadianDealerOfferedRateMember2023-01-012023-06-300000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMemberwell:CanadianDealerOfferedRateMember2023-06-300000766704us-gaap:UnsecuredDebtMemberwell:UkDebtDue2028Member2023-06-300000766704us-gaap:UnsecuredDebtMemberwell:A450SeniorUnsecuredNotesDue2034Member2023-06-300000766704us-gaap:UnsecuredDebtMember2022-12-310000766704us-gaap:UnsecuredDebtMember2021-12-310000766704us-gaap:UnsecuredDebtMember2023-01-012023-06-300000766704us-gaap:UnsecuredDebtMember2022-01-012022-06-300000766704us-gaap:UnsecuredDebtMember2022-06-300000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2023-05-310000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2023-05-012023-05-310000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2023-04-012023-06-300000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2023-06-30well:day0000766704us-gaap:SecuredDebtMember2022-12-310000766704us-gaap:SecuredDebtMember2021-12-310000766704us-gaap:SecuredDebtMember2023-01-012023-06-300000766704us-gaap:SecuredDebtMember2022-01-012022-06-300000766704us-gaap:SecuredDebtMember2022-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2022-06-300000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2023-06-300000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2022-12-310000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:GBP2023-06-300000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:GBP2022-12-310000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2023-01-012023-06-300000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2022-01-012022-12-310000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:GBP2023-01-012023-06-300000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:GBP2022-01-012022-12-310000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMembercurrency:USD2023-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMembercurrency:USD2022-12-310000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMembercurrency:USD2023-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMembercurrency:USD2022-12-310000766704us-gaap:NondesignatedMembercurrency:USD2023-06-300000766704us-gaap:NondesignatedMembercurrency:USD2022-12-310000766704currency:CADus-gaap:NondesignatedMember2023-06-300000766704currency:CADus-gaap:NondesignatedMember2022-12-310000766704us-gaap:DesignatedAsHedgingInstrumentMember2023-04-012023-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMember2022-04-012022-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-06-300000766704us-gaap:NondesignatedMember2023-04-012023-06-300000766704us-gaap:NondesignatedMember2022-04-012022-06-300000766704us-gaap:NondesignatedMember2023-01-012023-06-300000766704us-gaap:NondesignatedMember2022-01-012022-06-300000766704us-gaap:WarrantMember2023-04-012023-06-300000766704us-gaap:WarrantMember2022-04-012022-06-300000766704us-gaap:WarrantMember2023-01-012023-06-300000766704us-gaap:WarrantMember2022-01-012022-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherComprehensiveIncomeMember2023-04-012023-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherComprehensiveIncomeMember2022-04-012022-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherComprehensiveIncomeMember2023-01-012023-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherComprehensiveIncomeMember2022-01-012022-06-30well:obligation0000766704well:CapitalImprovementsMember2023-06-300000766704well:AtTheMarketProgramMember2023-05-310000766704well:AtTheMarketProgramMember2023-06-300000766704us-gaap:SubsequentEventMemberwell:AtTheMarketProgramMember2023-07-012023-07-310000766704us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300000766704us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000766704us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-06-300000766704us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310000766704us-gaap:EmployeeStockOptionMember2022-01-012022-06-300000766704us-gaap:EmployeeStockOptionMember2023-01-012023-06-300000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:MortgagesMember2023-06-300000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MortgagesMember2023-06-300000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:MortgagesMember2022-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MortgagesMember2022-12-310000766704well:OtherRealEstateLoansReceivableMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-06-300000766704well:OtherRealEstateLoansReceivableMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-06-300000766704well:OtherRealEstateLoansReceivableMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310000766704well:OtherRealEstateLoansReceivableMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-06-300000766704us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-06-300000766704us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2023-06-300000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2023-06-300000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2022-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2022-12-310000766704us-gaap:FairValueInputsLevel1Member2023-06-300000766704us-gaap:FairValueInputsLevel2Member2023-06-300000766704us-gaap:FairValueInputsLevel3Member2023-06-300000766704us-gaap:WarrantMember2022-12-310000766704us-gaap:WarrantMember2021-12-310000766704us-gaap:WarrantMember2023-01-012023-06-300000766704us-gaap:WarrantMember2022-01-012022-06-300000766704us-gaap:WarrantMember2023-06-300000766704us-gaap:WarrantMember2022-06-300000766704well:TerminalCapitalizationRateMember2023-06-300000766704well:TerminalCapitalizationRateMember2022-06-30well:segment0000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMemberus-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMemberus-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMemberwell:OutpatientMedicalMember2023-04-012023-06-300000766704us-gaap:CorporateNonSegmentMemberus-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2023-04-012023-06-300000766704us-gaap:CorporateNonSegmentMember2023-04-012023-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2023-04-012023-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-04-012023-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2023-04-012023-06-300000766704us-gaap:CorporateNonSegmentMemberwell:InterestRevenueMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:SeniorHousingOperatingMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMemberus-gaap:ProductAndServiceOtherMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:OutpatientMedicalMember2023-04-012023-06-300000766704us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2023-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2023-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMemberus-gaap:ManagementServiceMember2022-04-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMemberus-gaap:ManagementServiceMember2022-04-012022-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMemberwell:OutpatientMedicalMember2022-04-012022-06-300000766704us-gaap:CorporateNonSegmentMemberus-gaap:ManagementServiceMember2022-04-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2022-04-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2022-04-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2022-04-012022-06-300000766704us-gaap:CorporateNonSegmentMember2022-04-012022-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2022-04-012022-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:TripleNetMember2022-04-012022-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2022-04-012022-06-300000766704us-gaap:CorporateNonSegmentMemberwell:InterestRevenueMember2022-04-012022-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:SeniorHousingOperatingMember2022-04-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMemberus-gaap:ProductAndServiceOtherMember2022-04-012022-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:OutpatientMedicalMember2022-04-012022-06-300000766704us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2022-04-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMemberus-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMemberus-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMemberwell:OutpatientMedicalMember2023-01-012023-06-300000766704us-gaap:CorporateNonSegmentMemberus-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2023-01-012023-06-300000766704us-gaap:CorporateNonSegmentMember2023-01-012023-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2023-01-012023-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-01-012023-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2023-01-012023-06-300000766704us-gaap:CorporateNonSegmentMemberwell:InterestRevenueMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:SeniorHousingOperatingMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMemberus-gaap:ProductAndServiceOtherMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:OutpatientMedicalMember2023-01-012023-06-300000766704us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMemberus-gaap:ManagementServiceMember2022-01-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMemberus-gaap:ManagementServiceMember2022-01-012022-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMemberwell:OutpatientMedicalMember2022-01-012022-06-300000766704us-gaap:CorporateNonSegmentMemberus-gaap:ManagementServiceMember2022-01-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2022-01-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2022-01-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2022-01-012022-06-300000766704us-gaap:CorporateNonSegmentMember2022-01-012022-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2022-01-012022-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:TripleNetMember2022-01-012022-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2022-01-012022-06-300000766704us-gaap:CorporateNonSegmentMemberwell:InterestRevenueMember2022-01-012022-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:SeniorHousingOperatingMember2022-01-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMemberus-gaap:ProductAndServiceOtherMember2022-01-012022-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:OutpatientMedicalMember2022-01-012022-06-300000766704us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2022-01-012022-06-300000766704country:US2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:US2022-04-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:SalesRevenueNetMember2022-04-012022-06-300000766704country:US2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:US2022-01-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:SalesRevenueNetMember2022-01-012022-06-300000766704country:GB2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:GB2022-04-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:SalesRevenueNetMember2022-04-012022-06-300000766704country:GB2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:GB2022-01-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:SalesRevenueNetMember2022-01-012022-06-300000766704country:CA2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:CAus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:CA2022-04-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:CAus-gaap:SalesRevenueNetMember2022-04-012022-06-300000766704country:CA2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:CAus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:CA2022-01-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:CAus-gaap:SalesRevenueNetMember2022-01-012022-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-04-012022-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-06-300000766704country:USus-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:USus-gaap:ManagementServiceMember2022-04-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-04-012022-06-300000766704country:USus-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:USus-gaap:ManagementServiceMember2022-01-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-06-300000766704country:GBus-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:GBus-gaap:ManagementServiceMember2022-04-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-04-012022-06-300000766704country:GBus-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:GBus-gaap:ManagementServiceMember2022-01-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-06-300000766704country:CAus-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:CAus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:CAus-gaap:ManagementServiceMember2022-04-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:CAus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-04-012022-06-300000766704country:CAus-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:CAus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:CAus-gaap:ManagementServiceMember2022-01-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:CAus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-04-012022-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-06-300000766704country:US2023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:AssetsTotalMember2023-01-012023-06-300000766704country:US2022-12-310000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:AssetsTotalMember2022-01-012022-12-310000766704country:GB2023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:AssetsTotalMember2023-01-012023-06-300000766704country:GB2022-12-310000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:AssetsTotalMember2022-01-012022-12-310000766704country:CA2023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMembercountry:CA2023-01-012023-06-300000766704country:CA2022-12-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMembercountry:CA2022-01-012022-12-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMember2022-01-012022-12-310000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-06-300000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-12-31

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
   
 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2023
or
   
 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                     to                      
Commission file number: 1-8923
WELLTOWER INC.
 
(Exact name of registrant as specified in its charter
Delaware
34-1096634
(State or other jurisdiction
of Incorporation)
(IRS Employer
Identification No.)
4500 Dorr StreetToledo,Ohio43615
(Address of principal executive office)(Zip Code)
(419) -247-2800
(Registrant’s telephone number, including area code)  
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $1.00 par value per shareWELLNew York Stock Exchange
Guarantee of 4.800% Notes due 2028 issued by Welltower OP LLCWELL/28New York Stock Exchange
Guarantee of 4.500% Notes due 2034 issued by Welltower OP LLCWELL/34New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  þ  No  ¨
Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ  No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 þ
 Accelerated filer
¨
 Non-accelerated filer
¨
 Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No  þ
As of July 28, 2023, Welltower Inc. had 518,729,078 shares of common stock outstanding.





TABLE OF CONTENTS
 
 
PART I. FINANCIAL INFORMATIONPage
  
Item 1. Financial Statements (Unaudited)
Consolidated Balance Sheets
  
Consolidated Statements of Comprehensive Income
  
Consolidated Statements of Equity
  
Consolidated Statements of Cash Flows
  
Notes to Unaudited Consolidated Financial Statements
  
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
  
Item 3. Quantitative and Qualitative Disclosures About Market Risk
  
Item 4. Controls and Procedures
  
PART II. OTHER INFORMATION 
  
Item 1. Legal Proceedings
  
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
  
Item 5. Other Information
  
Item 6. Exhibits
  
Signatures



PART I. FINANCIAL INFORMATION

CONSOLIDATED BALANCE SHEETS
WELLTOWER INC. AND SUBSIDIARIES
(In thousands) 
June 30, 2023 (Unaudited)December 31, 2022 (Note)
Assets:  
  
Real estate investments:  
  
Real property owned:  
Land and land improvements  $4,262,745 $4,249,834 
Buildings and improvements  34,127,012 33,651,336 
Acquired lease intangibles  1,950,349 1,945,458 
Real property held for sale, net of accumulated depreciation  404,071 133,058 
Construction in progress  1,108,773 1,021,080 
Less accumulated depreciation and amortization  (8,599,622)(8,075,733)
Net real property owned  33,253,328 32,925,033 
Right of use assets, net322,316 323,942 
Real estate loans receivable, net of credit allowance  965,509 890,844 
Net real estate investments  34,541,153 34,139,819 
Other assets:  
Investments in unconsolidated entities  1,650,133 1,499,790 
Goodwill  68,321 68,321 
Cash and cash equivalents  2,203,788 631,681 
Restricted cash  95,281 90,611 
Straight-line rent receivable389,381 322,173 
Receivables and other assets  1,116,078 1,140,838 
Total other assets  5,522,982 3,753,414 
Total assets  
$40,064,135 $37,893,233 
Liabilities and equity  
Liabilities:  
Unsecured credit facility and commercial paper$ $ 
Senior unsecured notes  13,530,788 12,437,273 
Secured debt  2,460,349 2,110,815 
Lease liabilities348,770 415,824 
Accrued expenses and other liabilities  1,531,114 1,535,325 
Total liabilities  
17,871,021 16,499,237 
Redeemable noncontrolling interests  
369,191 384,443 
Equity:  
Common stock  509,805 491,919 
Capital in excess of par value  28,085,297 26,742,750 
Treasury stock  (112,032)(111,001)
Cumulative net income  8,933,663 8,804,950 
Cumulative dividends  (16,116,698)(15,514,097)
Accumulated other comprehensive income (loss)  (95,594)(119,707)
Total Welltower Inc. stockholders’ equity  21,204,441 20,294,814 
Noncontrolling interests  619,482 714,739 
Total equity  
21,823,923 21,009,553 
Total liabilities and equity  
$40,064,135 $37,893,233 
Note: The consolidated balance sheet at December 31, 2022 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

3


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands, except per share data) 
Three Months EndedSix Months Ended
June 30,June 30,
 2023202220232022
Revenues:  
Resident fees and services$1,159,449  $1,009,999 $2,291,134 $2,004,334 
Rental income  383,439 361,411 767,498 717,801 
Interest income38,710 37,140 75,115 76,134 
Other income83,880 63,986 92,460 69,971 
Total revenues1,665,478 1,472,536 3,226,207 2,868,240 
Expenses:
Property operating expenses958,672 854,083 1,916,425 1,707,752 
Depreciation and amortization341,945 310,295 681,057 614,383 
Interest expense152,337 127,750 296,740 249,446 
General and administrative expenses44,287 36,554 88,658 74,260 
Loss (gain) on derivatives and financial instruments, net1,280 (1,407)2,210 1,171 
Loss (gain) on extinguishment of debt, net1 603 6 591 
Provision for loan losses, net2,456 165 3,233 (639)
Impairment of assets1,086  13,715  
Other expenses11,069 35,166 33,814 61,235 
Total expenses1,513,133 1,363,209 3,035,858 2,708,199 
Income (loss) from continuing operations before income taxes and other items152,345 109,327 190,349 160,041 
Income tax (expense) benefit(3,503)(3,065)(6,548)(8,078)
Income (loss) from unconsolidated entities(40,332)(7,058)(47,403)(9,942)
Gain (loss) on real estate dispositions, net(2,168)(3,532)(1,421)19,402 
Income (loss) from continuing operations106,342 95,672 134,977 161,423 
Net income (loss)106,342 95,672 134,977 161,423 
Less: Net income (loss) attributable to noncontrolling interests(1)
3,302 5,888 6,264 9,714 
Net income (loss) attributable to common stockholders$103,040 $89,784 $128,713 $151,709 
Weighted average number of common shares outstanding:
Basic499,023 454,327 495,561 450,865 
Diluted501,970 457,082 498,305 453,455 
Earnings per share:
Basic:
Income (loss) from continuing operations$0.21 $0.21 $0.27 $0.36 
Net income (loss) attributable to common stockholders$0.21 $0.20 $0.26 $0.34 
Diluted:
Income (loss) from continuing operations$0.21 $0.21 $0.27 $0.36 
Net income (loss) attributable to common stockholders(2)
$0.20 $0.20 $0.26 $0.33 
Dividends declared and paid per common share$0.61 $0.61 $1.22 $1.22 
(1) Includes amounts attributable to redeemable noncontrolling interests.
(2) Includes adjustment to the numerator for income (loss) attributable to OP Units and DownREIT Units.

4


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands) 
 Three Months EndedSix Months Ended
June 30,June 30,
 2023202220232022
Net income (loss)$106,342 $95,672 $134,977 $161,423 
Other comprehensive income (loss):
Foreign currency translation gain (loss)119,519 (306,723)200,284 (373,671)
Derivative and financial instruments designated as hedges gain (loss)(85,884)284,081 (155,622)336,021 
Total other comprehensive income (loss)33,635 (22,642)44,662 (37,650)
Total comprehensive income (loss)139,977 73,030 179,639 123,773 
Less: Total comprehensive income (loss) attributable
to noncontrolling interests(1)
8,286 (10,031)14,127 (4,057)
Total comprehensive income (loss) attributable to common stockholders$131,691 $83,061 $165,512 $127,830 
(1) Includes amounts attributable to redeemable noncontrolling interests.

5


CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
Six Months Ended June 30, 2023
Common StockCapital in
Excess of
Par Value
Treasury
Stock
Cumulative
Net Income
Cumulative
Dividends
Accumulated Other
Comprehensive
Income (Loss)
Noncontrolling
Interests
Total
Balances at January 1, 2023$491,919 $26,742,750 $(111,001)$8,804,950 $(15,514,097)$(119,707)$714,739 $21,009,553 
Comprehensive income:
Net income (loss)   25,673   2,688 28,361 
Other comprehensive income (loss)    8,148 3,023 11,171 
Total comprehensive income       39,532 
Net change in noncontrolling interests (8,304)    29,648 21,344 
Adjustment to members' interest from change in ownership in Welltower OP (6,139)    6,139  
Redemption of OP Units and DownREIT Units272 17,515    (432)17,355 
Amounts related to stock incentive plans, net of forfeitures134 9,330 (1,924)    7,540 
Net proceeds from issuance of common stock5,603 404,862      410,465 
Dividends paid:
Common stock dividends    (301,829)  (301,829)
Balances at March 31, 2023$497,928 $27,160,014 $(112,925)$8,830,623 $(15,815,926)$(111,559)$755,805 $21,203,960 
Comprehensive income:
Net income (loss)103,040 3,505 106,545 
Other comprehensive income (loss)28,651 4,410 33,061 
Total comprehensive income139,606 
Net change in noncontrolling interests8,579 (12,686)(149,013)(153,120)
Adjustment to members' interest from change in ownership in Welltower OP(4,794)4,794  
Redemption of OP Units and DownREIT Units1 18 (19) 
Amounts related to stock incentive plans, net of forfeitures43 11,088 893 12,024 
Net proceeds from issuance of common stock11,833 910,392 922,225 
Dividends paid:
Common stock dividends(300,772)(300,772)
Balances at June 30, 2023$509,805 $28,085,297 $(112,032)$8,933,663 $(16,116,698)$(95,594)$619,482 $21,823,923 

















6


CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)

 Six Months Ended June 30, 2022
 Common StockCapital in
Excess of
Par Value
Treasury
Stock
Cumulative
Net Income
Cumulative
Dividends
Accumulated Other
Comprehensive
Income (Loss)
Noncontrolling
Interests
Total
Balances at January 1, 2022$448,605 $23,133,641 $(107,750)$8,663,736 $(14,380,915)$(121,316)$960,578 $18,596,579 
Comprehensive income:
Net income (loss)61,925 2,752 64,677 
Other comprehensive income (loss)(17,156)1,465 (15,691)
Total comprehensive income48,986 
Net change in noncontrolling interests(63,026)(128,305)(191,331)
Amounts related to stock incentive plans, net of forfeitures166 7,279 (4,768)2,677 
Net proceeds from issuance of common stock6,605 542,218 548,823 
Dividends paid:
Common stock dividends(273,668)(273,668)
Balances at March 31, 2022$455,376 $23,620,112 $(112,518)$8,725,661 $(14,654,583)$(138,472)$836,490 $18,732,066 
Comprehensive income:
Net income (loss)89,785 4,409 94,194 
Other comprehensive income (loss)(6,724)(15,116)(21,840)
Total comprehensive income72,354 
Net change in noncontrolling interests(6,760)118,793 112,033 
Adjustment to members' interest from change in ownership in Welltower OP46,861 (46,861) 
Amounts related to stock incentive plans, net of forfeitures20 6,551 827 7,398 
Net proceeds from issuance of common stock9,382 798,277 807,659 
Dividends paid:
Common stock dividends(277,615)(277,615)
Balances at June 30, 2022$464,778 $24,465,041 $(111,691)$8,815,446 $(14,932,198)$(145,196)$897,715 $19,453,895 

7


CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
Six Months Ended
June 30,
 20232022
Operating activities:    
Net income  $134,977 $161,423 
Adjustments to reconcile net income to net cash provided from (used in) operating activities:  
Depreciation and amortization  
681,057 614,383 
Other amortization expenses  
20,086 11,433 
Provision for loan losses, net3,233 (639)
Impairment of assets  
13,715  
Stock-based compensation expense  
19,960 13,466 
Loss (gain) on derivatives and financial instruments, net  
2,210 1,171 
Loss (gain) on extinguishment of debt, net  
6 591 
Loss (income) from unconsolidated entities
47,403 9,942 
Rental income less than (in excess of) cash received  
(71,997)(51,445)
Amortization related to above (below) market leases, net  
(248)(803)
Loss (gain) on real estate dispositions, net  
1,421 (19,402)
Loss (gain) on loss of control of subsidiary(65,485) 
Distributions by unconsolidated entities
6,895 9,590 
Increase (decrease) in accrued expenses and other liabilities  
(9,380)7,234 
Decrease (increase) in receivables and other assets  
8,450 (37,613)
Net cash provided from (used in) operating activities  792,303 719,331 
 
Investing activities:  
Cash disbursed for acquisitions, net of cash acquired
(424,094)(1,471,767)
Cash disbursed for capital improvements to existing properties
(204,978)(200,069)
Cash disbursed for construction in progress
(474,115)(286,427)
Capitalized interest  
(22,205)(11,866)
Investment in loans receivable
(76,397)(117,565)
Principal collected on loans receivable  
46,493 161,180 
Other investments, net of payments  
(95,819)3,919 
Contributions to unconsolidated entities  
(206,160)(307,513)
Distributions by unconsolidated entities  
125,176 13,641 
Proceeds from (payments on) derivatives  
3,933 27,302 
Proceeds from sales of real property  
1,950 103,904 
Net cash provided from (used in) investing activities  (1,326,216)(2,085,261)
Financing activities:  
Net increase (decrease) under unsecured credit facility and commercial paper
 29,065 
Net proceeds from issuance of senior unsecured notes1,011,427 1,040,232 
Net proceeds from the issuance of secured debt  
373,462 10,344 
Payments on secured debt  
(101,277)(226,854)
Net proceeds from the issuance of common stock  
1,333,908 1,357,561 
Payments for deferred financing costs and prepayment penalties  
(6,958)(4,081)
Contributions by noncontrolling interests(1)
181,272 38,065 
Distributions to noncontrolling interests(1)
(80,672)(214,288)
Cash distributions to stockholders  
(603,597)(549,842)
Other financing activities
(5,254)(6,586)
Net cash provided from (used in) financing activities  2,102,311 1,473,616 
Effect of foreign currency translation on cash and cash equivalents and restricted cash8,379 (12,190)
Increase (decrease) in cash, cash equivalents and restricted cash  1,576,777 95,496 
Cash, cash equivalents and restricted cash at beginning of period  722,292 346,755 
Cash, cash equivalents and restricted cash at end of period  $2,299,069 $442,251 
Supplemental cash flow information:
Interest paid$273,979 $207,031 
Income taxes paid (received), net1,157 5,462 
(1) Includes amounts attributable to redeemable noncontrolling interests.

8

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

1. Business
Welltower Inc., an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. We invest with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience. Welltower Inc., a real estate investment trust (“REIT”), owns interests in properties concentrated in major, high-growth markets in the United States (“U.S.”), Canada and the United Kingdom (“U.K.”), consisting of seniors housing and post-acute communities and outpatient medical properties. 
As of May 24, 2022, we are structured as an umbrella partnership REIT under which substantially all of our business is conducted through Welltower OP LLC, the day-to-day management of which is exclusively controlled by Welltower Inc. Unless stated otherwise or the context otherwise requires, references to "Welltower" mean Welltower Inc. and references to "Welltower OP" mean Welltower OP LLC. References to "we," "us" and "our" mean collectively Welltower, Welltower OP and those entities/subsidiaries owned or controlled by Welltower and/or Welltower OP. Welltower's weighted average ownership in Welltower OP was 99.729% for the six months ended June 30, 2023. As of June 30, 2023, Welltower owned 99.727% of the issued and outstanding units of Welltower OP, with other investors owning the remaining 0.273% of outstanding units. We adjust the noncontrolling members' interest at the end of each period to reflect their interest in the net assets of Welltower OP.
2. Accounting Policies and Related Matters
Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (such as normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2023 are not necessarily an indication of the results that may be expected for the year ending December 31, 2023. For further information, refer to the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022.
Impact of COVID-19 Pandemic & Government Grants
The extent to which the COVID-19 pandemic impacts our operations and those of our operators and tenants in the future is uncertain and cannot be predicted with confidence. We have received government grants under the CARES Act, as well as under similar programs in the U.K. and Canada, primarily to cover increased expenses and lost revenue during the COVID-19 pandemic. We recognized $11,019,000 and $15,155,000 during the three and six months ended June 30, 2023, respectively, as compared to $21,804,000 and $27,564,000 during the three and six ended June 30, 2022, respectively. These grants represent a reduction to property operating expenses in our Consolidated Statements of Comprehensive Income. The amount of qualifying expenditures and lost revenue exceeded grant income recognized and we believe we have complied and will continue to comply with all grant conditions. In the event of non-compliance, all such amounts are subject to recapture.
New Accounting Standards   
In March 2020, the FASB issued an amendment to the reference rate reform standard, which provides the option for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on contract modifications and hedge accounting. An example of such reform is the expected market transition from the London Interbank Offered Rate ("LIBOR") and other interbank offered rates to alternative reference rates. Entities that make this optional expedient election would not have to remeasure the contracts at the modification date or reassess the accounting treatment if certain criteria are met and would continue applying hedge accounting for relationships affected by reference rate reform. In December 2022, the FASB extended the date for which this guidance can be applied from December 31, 2022 to December 31, 2024. We continue to monitor developments related to the LIBOR transition and identification of an alternative, market-accepted rate.
3. Real Property Acquisitions and Development 
The total purchase price for all properties acquired has been allocated to the tangible and identifiable intangible assets and liabilities at cost on a relative fair value basis. Liabilities assumed and any associated noncontrolling interests are reflected at fair value. The results of operations for these acquisitions have been included in our consolidated results of operations since the date of acquisition and are a component of the appropriate segments. Transaction costs primarily represent costs incurred with acquisitions, including due diligence costs, fees for legal and valuation services, termination of pre-existing relationships computed based on the fair value of the assets acquired, lease termination fees and other acquisition-related costs. Transaction costs related to asset acquisitions are capitalized as a component of purchase price and all other non-capitalizable costs are reflected in other expenses on our Consolidated Statements of Comprehensive Income.
9

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The following is a summary of our real property investment activity by segment for the periods presented (in thousands):
 Six Months Ended
 June 30, 2023June 30, 2022
Seniors Housing OperatingTriple-netOutpatient
Medical
TotalsSeniors Housing OperatingTriple-netOutpatient
Medical
Totals
Land and land improvements$4,426 $7,370 $60,527 $72,323 $130,282 $ $26,714 $156,996 
Buildings and improvements50,172 74,289 256,190 380,651 1,249,982 171 205,161 1,455,314 
Acquired lease intangibles970  39,090 40,060 77,705  26,836 104,541 
Construction in progress    108,141   108,141 
Right of use assets, net  927 927 169  3,852 4,021 
Total net real estate assets55,568 81,659 356,734 493,961 1,566,279 171 262,563 1,829,013 
Receivables and other assets2,089  358 2,447 6,091  260 6,351 
Total assets acquired(1)
57,657 81,659 357,092 496,408 1,572,370 171 262,823 1,835,364 
Secured debt(21,767) (40,953)(62,720)(219,067)  (219,067)
Lease liabilities  (953)(953)  (3,852)(3,852)
Accrued expenses and other liabilities(570) (8,071)(8,641)(11,937) (393)(12,330)
Total liabilities acquired(22,337) (49,977)(72,314)(231,004) (4,245)(235,249)
Noncontrolling interests (2)
    (101,885)(4)(664)(102,553)
Non-cash acquisition related activity(3)
    (25,795)  (25,795)
Cash disbursed for acquisitions35,320 81,659 307,115 424,094 1,213,686 167 257,914 1,471,767 
Construction in progress additions295,120 25,646 190,164 510,930 229,044 45,939 24,336 299,319 
Less: Capitalized interest(16,761)(2,416)(3,028)(22,205)(9,305)(2,031)(530)(11,866)
Accruals (4)
746 (9,384)(5,972)(14,610)(3,479) 2,453 (1,026)
Cash disbursed for construction in progress279,105 13,846 181,164 474,115 216,260 43,908 26,259 286,427 
Capital improvements to existing properties165,187 11,784 28,007 204,978 146,052 25,016 29,001 200,069 
Total cash invested in real property, net of cash acquired$479,612 $107,289 $516,286 $1,103,187 $1,575,998 $69,091 $313,174 $1,958,263 
(1) Excludes $5,491,000 of unrestricted and restricted cash acquired during the six months ended June 30, 2022.
(2) Includes amounts attributable to both redeemable noncontrolling interests and noncontrolling interests. For the six months ended June 30, 2022, 1,145,000 Welltower OP units were issued as a component of funding for certain transactions.
(3) Relates to the acquisition of assets recognized as investments in unconsolidated entities.
(4) Represents non-cash accruals for amounts to be paid in future periods for properties that converted, offset by amounts paid in the current period.
Effective on April 1, 2022, our leasehold interest relating to the master lease with National Health Investors, Inc. ("NHI") for 17 properties assumed in conjunction with the Holiday Retirement acquisition was terminated as a result of the transition or sale of the properties by NHI. The lease termination was part of an agreement to resolve outstanding litigation with NHI. In conjunction with the agreement, a wholly owned subsidiary and the lessee on the master lease agreed to release $6,883,000 of cash to the landlord, which represents the net cash flow generated from the properties since we assumed the leasehold interest. Additionally, in connection with the lease termination, during the three months ended June 30, 2022, we recognized $58,621,000 in other income on our Consolidated Statements of Comprehensive Income from the derecognition of the right of use asset and related lease liability.
Construction Activity 
The following is a summary of the construction projects that were placed into service and began generating revenues during the periods presented (in thousands):
 Six Months Ended
 June 30, 2023June 30, 2022
Development projects:
Seniors Housing Operating
$140,865 $134,562 
Triple-net
141,142  
Outpatient Medical
21,173  
Total development projects
303,180 134,562 
Expansion projects
26,125  
Total construction in progress conversions$329,305 $134,562 
10

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
4. Real Estate Intangibles 
The following is a summary of our real estate intangibles, excluding those related to ground leases or classified as held for sale, as of the dates indicated (dollars in thousands):
 June 30, 2023December 31, 2022
Assets:
In place lease intangibles$1,802,091 $1,817,580 
Above market tenant leases66,354 57,203 
Lease commissions81,904 70,675 
Gross historical cost1,950,349 1,945,458 
Accumulated amortization(1,552,953)(1,484,048)
Net book value$397,396 $461,410 
Liabilities:
Below market tenant leases$82,084 $77,985 
Accumulated amortization(56,784)(52,701)
Net book value$25,300 $25,284 
The following is a summary of real estate intangible amortization income (expense) for the periods presented (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Rental income related to (above)/below market tenant leases, net$130 $351 $175 $736 
Amortization related to in place lease intangibles and lease commissions(53,774)(50,194)(109,925)(98,188)
5. Dispositions, Real Property Held for Sale and Impairment
We periodically sell properties for various reasons, including favorable market conditions, the exercise of tenant purchase options or reduction of concentrations (i.e., property type, relationship or geography). At June 30, 2023, 18 Seniors Housing Operating properties, one Triple-net property and one Outpatient Medical property with an aggregate real estate balance of $404,071,000 were classified as held for sale. In addition to the real property balances, secured debt balances of $171,711,000 and net other assets and (liabilities) of $26,950,000 are included in the Consolidated Balance Sheets related to the held for sale properties. Expected gross sales proceeds related to the held for sale properties are approximately $456,859,000.
During the six months ended June 30, 2023, we recorded $13,715,000 of impairment charges related to two Seniors Housing Operating properties and one Triple-net property classified as held for sale for which the carrying value exceeded the estimated fair value less costs to sell and one Seniors Housing Operating property classified as held for use for which the carrying value exceeded the estimated fair value. We did not record any impairment charges during the six months ended June 30, 2022.
Operating results attributable to properties sold or classified as held for sale which do not meet the definition of discontinued operations are not reclassified on our Consolidated Statements of Comprehensive Income. We recognized income (loss) from continuing operations before income taxes and other items from properties sold or classified as held for sale as of June 30, 2023 of $65,362,000 and $54,381,000 for the three and six months ended June 30, 2023 and $1,588,000 and $2,602,000 for the same periods in 2022, respectively.
The following is a summary of our real property disposition activity for the periods presented (in thousands):
 Six Months Ended
 June 30, 2023June 30, 2022
Real estate dispositions:
Seniors Housing Operating
$243,695 $13,470 
Triple-net
2,028 70,571 
Total dispositions
245,723 84,041 
Gain (loss) on real estate dispositions, net(1,421)19,402 
Net other assets/(liabilities) disposed(624)461 
 Non-cash consideration (241,728) 
Cash proceeds from real estate dispositions$1,950 $103,904 

11

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Strategic Dissolution of Revera Joint Ventures
During the three months ended June 30, 2023, we entered into definitive agreements to dissolve our existing Revera joint venture relationships across the U.S., U.K. and Canada. The transactions include acquiring the remaining interests in 110 properties from Revera while simultaneously selling interests in 31 properties to Revera.
During the second quarter, we closed the U.K. portfolio portion of the transaction through the acquisition of the remaining ownership interest in 29 properties previously held in two separate consolidated joint venture structures in which we owned 75% and 90% of the interests in exchange for the disposition to Revera of our interests in four properties. In addition, we received cash from Revera of $107,341,000 relating to the net settlement of loans previously made to the joint ventures. Operations for the 29 retained properties were transitioned to Avery Healthcare.
Total proceeds related to the four properties disposed were $222,521,000, which included non-cash consideration from Revera of $241,728,000, comprised of the fair value of interests received by us of $198,837,000 and an allocation of Revera's noncontrolling interests of $42,891,000, partially offset by $9,049,000 of transaction-related expenses as well as the $10,158,000 of cash paid to equalize the value exchanged between the parties. We disposed of net real property owned of $224,208,000, resulting in a loss of $1,687,000 recognized within gain (loss) on real estate dispositions, net within our Consolidated Statements of Comprehensive Income. Consideration transferred to acquire the additional interests in the 29 properties was comprised of the fair value of interests transferred by us of $198,837,000 and $5,776,000 of cash paid for transaction-related expenses. We derecognized $180,497,000 of noncontrolling interests and $22,270,000 of liabilities previously due to Revera with an adjustment of $1,846,000 recognized in capital in excess of par value. The non-cash investing activity with respect to the sale of the four properties and non-cash financing activity with respect to the acquisition of Revera's interests in the 29 properties has been excluded from our Consolidated Statement of Cash Flows.
In July, we closed transactions related primarily to our U.S portfolio through (i) the acquisition of ten properties currently under development or recently developed by Sunrise Senior Living, previously held 34% by us/66% by Revera within an equity method joint venture for an additional investment of approximately $286 million, (ii) the disposition of our minority interests in 12 U.S. properties and one Canadian development project for approximately $216 million, and (iii) the disposition of our 34% interest in the Sunrise Senior Living management company. During the three months ended June 30, 2023, we recognized an impairment charge of $27,708,000 in income from unconsolidated entities on our Consolidated Statements of Comprehensive Income based on estimated sales proceeds for the sale of the Sunrise Senior Living management company. Operations for two of the now wholly-owned properties, along with operations for 26 existing wholly-owned properties, transitioned to Oakmont Management Group.
We anticipate closing the remainder of the transaction related to our Canadian portfolio before December 31, 2023. The Canadian portfolio consists of 85 properties in a joint venture owned 75% by us and 25% by Revera. As a part of the transaction we intend to acquire Revera's interest in 71 properties and sell our interests in the remaining 14 properties.
Genesis HealthCare
As part of the substantial exit of the Genesis HealthCare operating relationship, which we disclosed on March 2, 2021, we transitioned the sublease of a portfolio of seven facilities from Genesis HealthCare to Complete Care Management in the second quarter of 2021. As part of the March 2021 transaction, we entered into a forward sale agreement for the seven properties valued at $182,618,000, which was expected to close when the Welltower-held purchase option became exercisable. As of March 31, 2023, the right of use assets related to the properties were $115,359,000 and were reflected as held for sale with the corresponding lease liabilities of $66,530,000 on our Consolidated Balance Sheet.
On May 1, 2023, we executed a series of transactions that included the assignment of the leasehold interest to a newly formed tri-party unconsolidated joint venture with Aurora Health Network, Peace Capital (an affiliate of Complete Care Management) and us, and culminated with the closing of the purchase option by the joint venture. The transactions resulted in net cash proceeds to us of $104,240,000 (excluded from the dispositions table above) after our retained interest of $11,571,000 in the joint venture and a gain from the loss of control and derecognition of the leasehold interest of $65,485,000, which we recorded in other income within our Consolidated Statements of Comprehensive Income.
6. Leases
We lease land, buildings, office space and certain equipment. Many of our leases include a renewal option to extend the term from one to 25 years or more. Renewal options that we are reasonably certain to exercise are recognized in our right-of-use assets and lease liabilities.


12

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The components of lease expense were as follows for the periods presented (in thousands):
Six Months Ended
 ClassificationJune 30, 2023June 30, 2022
Operating lease cost: (1)
Real estate lease expenseProperty operating expenses$11,093 $11,209 
Non-real estate investment lease expenseGeneral and administrative expenses3,586 2,101 
Finance lease cost:
Amortization of leased assetsProperty operating expenses3,628 3,171 
Interest on lease liabilitiesInterest expense1,980 2,937 
Sublease incomeRental income(3,933)(5,587)
Total $16,354 $13,831 
(1) Includes short-term leases which are immaterial.
Supplemental balance sheet information related to leases in which we are the lessee is as follows (in thousands):
 ClassificationJune 30, 2023December 31, 2022
Right of use assets:
Operating leases - real estateRight of use assets, net$284,601 $287,984 
Finance leases - real estateRight of use assets, net37,715 35,958 
Real estate right of use assets, net322,316 323,942 
Operating leases - non-real estate investmentsReceivables and other assets8,433 10,119 
Finance leases - held for sale (1)
Real property held for sale, net of accumulated depreciation 116,453 
Total right of use assets, net$330,749 $450,514 
Lease liabilities:
Operating leases$299,377 $302,360 
Financing leases49,393 113,464 
Total$348,770 $415,824 
(1) During the quarter ended June 30, 2023, we contributed finance leases at seven properties which was previously classified as held for sale into a newly formed unconsolidated joint venture, which recognized the purchase option within the leases. See Note 5 for further discussion.
Substantially all of our operating leases in which we are the lessor contain escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectability assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. 
Leases in our Triple-net and Outpatient Medical portfolios recognized under ASC 842, "Leases" (ASC 842), typically include some form of operating expense reimbursement by the tenant. For the six months ended June 30, 2023, we recognized $767,498,000 of rental income related to operating leases, of which $108,566,000 was for variable lease payments that primarily represents the reimbursement of operating costs such as common area maintenance expenses, utilities, insurance and real estate taxes. For the six months ended June 30, 2022, we recognized $717,801,000 of rental income related to operating leases, of which $96,309,000 was for variable lease payments.
For the majority of our Seniors Housing Operating segment, revenue from resident fees and services is predominantly service-based, and as such, resident agreements are accounted for under ASC 606, "Revenue from Contracts with Customers." Within that reportable segment, we also recognize revenue from residential seniors apartment leases in accordance with ASC 842. The amount of revenue related to these leases was $222,452,000 and $198,052,000 for the six months ended June 30, 2023 and 2022, respectively.
7. Loans Receivable
Loans receivable are recorded on our Consolidated Balance Sheets in real estate loans receivable, net of allowance for credit losses, or for non-real estate loans receivable, in receivables and other assets. Real estate loans receivable consists of mortgage loans and other real estate loans which are primarily collateralized by a first, second or third mortgage lien, a leasehold mortgage on, or an assignment of the partnership interest in, the related properties, as well as corporate guarantees and/or personal guarantees. Non-real estate loans are generally corporate loans with no real estate backing. Interest income on loans is recognized as earned based upon the principal amount outstanding subject to an evaluation of the risk of credit loss. Accrued interest receivable was $26,641,000 and $22,878,000 as of June 30, 2023 and December 31, 2022, respectively, and is included in receivables and other assets on the Consolidated Balance Sheets. The following is a summary of our loans receivable (in thousands):

13

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
 June 30, 2023December 31, 2022
Mortgage loans$738,496 $707,464 
Other real estate loans239,920 195,566 
Allowance for credit losses on real estate loans receivable(12,907)(12,186)
Real estate loans receivable, net of credit allowance965,509 890,844 
Non-real estate loans470,786 441,231 
Allowance for credit losses on non-real estate loans receivable(173,433)(152,063)
Non-real estate loans receivable, net of credit allowance297,353 289,168 
Total loans receivable, net of credit allowance$1,262,862 $1,180,012 
The following is a summary of our loan activity for the periods presented (in thousands):    
 Six Months Ended
 June 30, 2023June 30, 2022
Advances on loans receivable$76,397 $117,565 
Less: Receipts on loans receivable46,493 161,180 
Net cash advances (receipts) on loans receivable$29,904 $(43,615)
The allowance for credit losses on loans receivable is maintained at a level believed adequate to absorb potential losses in our loans receivable. The determination of the credit allowance is based on a quarterly evaluation of each of these loans, including general economic conditions and estimated collectability of loan payments. We evaluate the collectability of our loans receivable based on a combination of credit quality indicators, including, but not limited to, payment status, historical loan charge-offs, financial strength of the borrower and guarantors, and nature, extent, and value of the underlying collateral.
A loan is considered to have deteriorated credit quality when, based on current information and events, it is probable that we will be unable to collect all amounts due as scheduled according to the contractual terms of the loan agreement. For those loans we identified as having deteriorated credit quality, we determine the amount of credit loss on an individual basis. Placement on non-accrual status may be required. Consistent with this definition, all loans on non-accrual are deemed to have deteriorated credit quality. To the extent circumstances improve and the risk of collectability is diminished, we will return these loans to income accrual status. While a loan is on non-accrual status, any cash receipts are applied against the outstanding principal balance.
For the remaining loans we assess credit loss on a collective pool basis and use our historical loss experience for similar loans to determine the reserve for credit losses. The following is a summary of our loans by credit loss category (in thousands):
June 30, 2023
Loan categoryYears of OriginationLoan Carrying ValueAllowance for Credit LossNet Loan BalanceNo. of Loans
Deteriorated loans2007 - 2023$213,105 $(169,978)$43,127 8 
Collective loan pool2007 - 2018216,440 (2,878)213,562 12 
Collective loan pool201923,397 (311)23,086 4 
Collective loan pool202033,891 (451)33,440 6 
Collective loan pool2021783,161 (10,339)772,822 14 
Collective loan pool2022118,720 (1,579)117,141 29 
Collective loan pool202360,488 (804)59,684 7 
Total loans$1,449,202 $(186,340)$1,262,862 80 
The total allowance for credit losses balance is deemed sufficient to absorb expected losses relating to our loan portfolio. The following is a summary of the allowance for credit losses on loans receivable for the periods presented (in thousands):                            
Six Months Ended
June 30, 2023June 30, 2022
Balance at beginning of period$164,249 $166,785 
Provision for loan losses, net3,233 (639)
Purchased deteriorated loan19,077  
Foreign currency translation(219)(1,063)
Balance at end of period$186,340 $165,083 
14

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

8. Investments in Unconsolidated Entities
We participate in a number of joint ventures, which generally invest in seniors housing and health care real estate. Our share of the results of operations for these properties has been included in our consolidated results of operations from the date of acquisition by the joint ventures and are reflected in our Consolidated Statements of Comprehensive Income as income or loss from unconsolidated entities. The following is a summary of our investments in unconsolidated entities (dollars in thousands): 
 
Percentage Ownership (1)
June 30, 2023December 31, 2022
Seniors Housing Operating
10% to 95%
$1,271,079 $1,171,307 
Triple-net